NCT03315936View on ClinicalTrials.gov

This Study in Healthy Men Tests How Different Doses of BI 894416 Are Taken up in the Body and How Well BI 894416 is Tolerated

PHASE1CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

November 2, 2017

Primary Completion Date

September 10, 2018

Study Completion Date

September 10, 2018

Conditions
Healthy
Interventions
DRUG

BI 894416

powder for oral solution

DRUG

Placebo

Oral solution

DRUG

BI 894416

Tablet

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03315936 - This Study in Healthy Men Tests How Different Doses of BI 894416 Are Taken up in the Body and How Well BI 894416 is Tolerated | Biotech Hunter | Biotech Hunter